Drug Utilization Evaluation on the Combination of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Taiwan

被引：0
|
作者：
Chang, Wen-Yi [1 ]
Chen, Li-Chia [1 ,2 ]
Cheng, Li-Jen [3 ]
机构：
[1] Kaohsiung Med Univ, Grad Inst Clin Pharm, Kaohsiung, Taiwan
[2] Univ Nottingham, Sch Pharm, Div Social Res Med & Hlth, Nottingham, England
[3] Univ Macau, Inst Chinese Med Sci, Macau, Peoples R China
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2010年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
335
引用
收藏
页码：S143 / S144
页数：2
相关论文
共 50 条
  • [31] In reply - Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
    Sanchis-Gomar, Fabian
    Lavie, Carl J.
    Perez-Quilis, Carme
    Henry, Brandon M.
    Lippi, Giuseppe
    MAYO CLINIC PROCEEDINGS, 2020, 95 (07) : 1553 - 1556
  • [32] Utilization, Price and Expenditure Trends for Both Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Medicaid Program
    Bian, Boyang
    Guo, Jeff
    Kelton, Chris
    Wigle, Patricia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S51 - S52
  • [33] Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
    Xiao-Long Li
    Tao Li
    Qi-Cong Du
    Li Yang
    Kun-Lun He
    World Journal of Clinical Cases, 2021, 9 (20) : 5462 - 5469
  • [34] Pneumonia Risk and Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
    Liu, Chia-Lin
    Shau, Wen-Yi
    Chang, Chia-Hsuin
    Wu, Chi-Shin
    Lai, Mei-Shu
    JOURNAL OF EPIDEMIOLOGY, 2013, 23 (05) : 344 - 350
  • [35] Anti-inflammatory action of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
    Mascitelli, L
    Pezzetta, F
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 889 - 889
  • [36] Tolerability of Angiotensin-Receptor Blockers in Patients with Intolerance to Angiotensin-Converting Enzyme Inhibitors
    Caldeira, Daniel
    David, Claudio
    Sampaio, Cristina
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2012, 12 (04) : 263 - 277
  • [37] Taste disturbance by angiotensin-converting enzyme inhibitors/angiotensin-2 receptor blockers
    Ebihara, Satoru
    Kohzuki, Masahiro
    KIDNEY INTERNATIONAL, 2010, 77 (07) : 649 - 649
  • [38] COVID-19 and the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
    St John, Megan H.
    Barry, Arden R.
    CANADIAN PHARMACISTS JOURNAL, 2020, 153 (04) : 193 - 197
  • [39] Association between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Lung Cancer
    Helgeson, Scott A.
    Waddle, Mark R.
    Burnside, Rebecca C.
    Debella, Yalew T.
    Lee, Augustine S.
    Burger, Charles D.
    Li, Zhuo
    Johnson, Patrick W.
    Patel, Neal M.
    SOUTHERN MEDICAL JOURNAL, 2021, 114 (09) : 607 - 613
  • [40] Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure
    McClellan, MB
    Loeb, JM
    Clancy, CM
    Francis, GS
    Jacobs, AK
    Kizer, KW
    O'Kane, ME
    Wolk, MJ
    ANNALS OF INTERNAL MEDICINE, 2005, 142 (05) : 386 - 387
12345